Table 1.

Patient characteristics

	Cohort 1	Cohort 2	Cohort 3
Booster HMFG1 dose (mg)	0.5	1	5
Number of patients	8	6	12
Mean age	58	48	49
Priming route (numbers i.v.:i.p.)	4:4	3:3	4:8
Number completing the regimen	4	1	8
Disease characteristics
Pathological 2nd complete remission	1	0	3
Microscopic disease	0	1	2
Residual disease <0.5 cm	4	2	3
Residual disease >0.5 cm	3	3	4